SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001161697-19-000018
Filing Date
2019-01-04
Accepted
2019-01-04 16:45:00
Documents
1
Period of Report
2018-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 FOR 12-27-2018 form_3.html 3  
1 FORM 3 FOR 12-27-2018 form_3.xml 3 7229
  Complete submission text file 0001161697-19-000018.txt   8833
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 355 ALHAMBRA CIRCLE CORAL GABLES FL 33134
Business Address
Elsbernd Brian (Reporting) CIK: 0001763511 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33057 | Film No.: 19510687